908 Devices

MASS · NASDAQ

$11.51+$0.08 (+0.70%)TodayMarket closed · Oct 20, 7:30 PM ET

Prev close $11.43

Latest news

NewsSep 18, 4:25 AM ETAvi Kapoor
Why Alaunos Therapeutics Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket
Press releaseSep 1, 7:00 AM ETBusiness Wire
908 Devices to Present at the 32nd Annual Gabelli Aerospace & Defense Symposium
Press releaseAug 12, 7:00 AM ETBusiness Wire
908 Devices to Present at the 17th Annual Midwest IDEAS Investor Conference
NewsAug 11, 1:06 PM ET
12 Information Technology Stocks Moving In Tuesday's Intraday Session
Press releaseAug 11, 7:00 AM ETBusiness Wire
908 Devices Reports Second Quarter 2026 Financial Results and Raises Low End of 2026 Revenue Outlook
Press releaseJul 29, 7:00 AM ETBusiness Wire
908 Devices to Participate in the Canaccord Genuity 46th Annual Growth Conference
Press releaseJul 28, 7:00 AM ETBusiness Wire
908 Devices to Report Second Quarter 2026 Financial Results on August 11, 2026
Press releaseJun 2, 4:30 PM ETBusiness Wire
908 Devices Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Press releaseMay 28, 7:00 AM ETBusiness Wire
908 Devices to Present at the 16th Annual East Coast IDEAS Investor Conference
NewsMay 6, 5:03 PM ET
Earnings Scheduled For May 6, 2026
Press releaseMay 6, 7:30 AM ETBusiness Wire
908 Devices Reports First Quarter 2026 Financial Results and Raises 2026 Revenue Outlook
Press releaseMay 6, 7:00 AM ETBusiness Wire
908 Devices Acquires NIRLAB AG, Expanding Its Narcotics Detection Portfolio
Press releaseMay 1, 8:30 AM ETBusiness Wire
908 Devices to Report First Quarter 2026 Financial Results on May 6, 2026
Press releaseApr 21, 5:00 PM ETBusiness Wire
908 Devices Appoints Kola Otitoju as Chief Business & Strategy Officer and Announces an Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Press releaseMar 16, 7:00 AM ETBusiness Wire
908 Devices to Present at the Sidoti Small Cap Conference
NewsMar 3, 7:02 AM ET
908 Devices Q4 EPS from continuing operations $0.11 Beats $(0.10) Estimate, Sales $17.380M Beat $15.843M Estimate
NewsMar 3, 7:02 AM ET
908 Devices Q4 Earnings Summary & Key Takeaways
Press releaseMar 3, 7:00 AM ETBusiness Wire
908 Devices Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Revenue Outlook
NewsMar 3, 6:11 AM ET
Earnings Scheduled For March 3, 2026
NewsMar 2, 1:02 PM ET
An Overview of 908 Devices's Earnings
Press releaseFeb 24, 7:00 AM ETBusiness Wire
908 Devices to Participate in Investor Conferences in March
Press releaseFeb 17, 7:00 AM ETBusiness Wire
908 Devices to Report Fourth Quarter and Full Year 2025 Financial Results on March 3, 2026
Press releaseFeb 5, 7:00 AM ETBusiness Wire
908 Devices Enhances MX908 Usability and Adds New Drug Targets
Press releaseJan 20, 7:00 AM ETBusiness Wire
908 Devices Announces Strong Preliminary Financial Results for Fourth Quarter and Full Year 2025
Press releaseNov 10, 7:00 AM ETBusiness Wire
908 Devices Reports Third Quarter 2025 Financial Results and Reiterates 2025 Revenue Outlook
Press releaseOct 30, 7:00 AM ETBusiness Wire
908 Devices to Participate in Upcoming Investor Conferences
Press releaseOct 28, 7:00 AM ETBusiness Wire
United States Coast Guard Purchases 908 Devices' Handheld Mass Spec Devices for Chemical Threat Identification
Press releaseOct 22, 7:00 AM ETBusiness Wire
908 Devices to Report Third Quarter 2025 Financial Results on November 10, 2025
Press releaseOct 16, 7:00 AM ETBusiness Wire
United States Marine Corps Purchases 908 Devices' XplorIR Gas Identification Devices
Press releaseAug 5, 7:00 AM ETBusiness Wire
908 Devices Reports Second Quarter 2025 Financial Results and Raises 2025 Revenue Outlook
NewsAug 5, 4:32 AM ET
Earnings Scheduled For August 5, 2025
Press releaseAug 4, 7:00 AM ETBusiness Wire
908 Devices Appoints Dr. Brandi Vann, former U.S. Principal Deputy Assistant Secretary for Nuclear, Chemical, and Biological Defense, to its Board of Directors
Press releaseJul 29, 7:00 AM ETBusiness Wire
908 Devices to Participate in the Canaccord Genuity 45th Annual Growth Conference
NewsMay 14, 5:05 PM ET
12 Information Technology Stocks Moving In Wednesday's After-Market Session
NewsMay 13, 1:06 PM ET
12 Information Technology Stocks Moving In Tuesday's Intraday Session

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

Why Alaunos Therapeutics Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket

908 Devices to Present at the 32nd Annual Gabelli Aerospace & Defense Symposium

908 Devices to Present at the 17th Annual Midwest IDEAS Investor Conference

12 Information Technology Stocks Moving In Tuesday's Intraday Session

908 Devices Reports Second Quarter 2026 Financial Results and Raises Low End of 2026 Revenue Outlook

908 Devices to Participate in the Canaccord Genuity 46th Annual Growth Conference

908 Devices to Report Second Quarter 2026 Financial Results on August 11, 2026

908 Devices Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

908 Devices to Present at the 16th Annual East Coast IDEAS Investor Conference

Earnings Scheduled For May 6, 2026

908 Devices Reports First Quarter 2026 Financial Results and Raises 2026 Revenue Outlook

908 Devices Acquires NIRLAB AG, Expanding Its Narcotics Detection Portfolio

908 Devices to Report First Quarter 2026 Financial Results on May 6, 2026

908 Devices Appoints Kola Otitoju as Chief Business & Strategy Officer and Announces an Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

908 Devices to Present at the Sidoti Small Cap Conference

908 Devices Q4 EPS from continuing operations $0.11 Beats $(0.10) Estimate, Sales $17.380M Beat $15.843M Estimate

908 Devices Q4 Earnings Summary & Key Takeaways

908 Devices Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Revenue Outlook

Earnings Scheduled For March 3, 2026

An Overview of 908 Devices's Earnings

908 Devices to Participate in Investor Conferences in March

908 Devices to Report Fourth Quarter and Full Year 2025 Financial Results on March 3, 2026

908 Devices Enhances MX908 Usability and Adds New Drug Targets

908 Devices Announces Strong Preliminary Financial Results for Fourth Quarter and Full Year 2025

908 Devices Reports Third Quarter 2025 Financial Results and Reiterates 2025 Revenue Outlook

908 Devices to Participate in Upcoming Investor Conferences

United States Coast Guard Purchases 908 Devices' Handheld Mass Spec Devices for Chemical Threat Identification

908 Devices to Report Third Quarter 2025 Financial Results on November 10, 2025

United States Marine Corps Purchases 908 Devices' XplorIR Gas Identification Devices

908 Devices Reports Second Quarter 2025 Financial Results and Raises 2025 Revenue Outlook

Earnings Scheduled For August 5, 2025

908 Devices Appoints Dr. Brandi Vann, former U.S. Principal Deputy Assistant Secretary for Nuclear, Chemical, and Biological Defense, to its Board of Directors

908 Devices to Participate in the Canaccord Genuity 45th Annual Growth Conference

12 Information Technology Stocks Moving In Wednesday's After-Market Session

12 Information Technology Stocks Moving In Tuesday's Intraday Session